No Data
No Data
Sinopharm is consistent: summary of the 2024 semi-annual report
Sinopharm is consistent: 2024 semi-annual report
China National Accord Medicines' H1 Profit Slips 11%, Revenue Down 2%; Shares Drop 4%
China National Accord Medicines Corporation: 2024 Half-Year Performance Bulletin
Private Companies Account for 57% of China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Ownership, While Individual Investors Account for 28%
China National Accord Medicines Corporation Ltd. (SZSE:000028) Passed Our Checks, And It's About To Pay A CN¥0.68 Dividend
No Data
No Data